Literature DB >> 10603968

Cardiac responses to calcium sensitizers and isoproterenol in intact guinea pig hearts. Effects on cyclic AMP levels, protein phosphorylation, myoplasmic calcium concentration, and left ventricular function.

E Kristof1, G Szigeti, Z Papp, A Bodi, A Facsko, L Kovacs, J G Papp, E G Kranias, I Edes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10603968     DOI: 10.1111/j.1749-6632.1998.tb08288.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

1.  Biphasic effect of bimoclomol on calcium handling in mammalian ventricular myocardium.

Authors:  P P Nánási; S Sárközi; G Szigeti; I Jóna; C Szegedi; A Szabó; T Bányász; J Magyar; P Szigligeti; A Körtvély; L Csernoch; L Kovács; A Jednákovits
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 2.  Levosimendan: A promising agent for the treatment of hospitalized patients with decompensated heart failure.

Authors:  L Lehtonen
Journal:  Curr Cardiol Rep       Date:  2000-05       Impact factor: 2.931

Review 3.  [Role of Levosimendan in intensive care treatment of myocardial insufficiency].

Authors:  S Rehberg; C Ertmer; H Van Aken; M Lange; K Bröking; A Morelli; M Westphal
Journal:  Anaesthesist       Date:  2007-01       Impact factor: 1.041

4.  Effect of severe renal failure and haemodialysis on the pharmacokinetics of levosimendan and its metabolites.

Authors:  Jaakko Puttonen; Sampo Kantele; Matti Kivikko; Sari Häkkinen; Veli-Pekka Harjola; Petri Koskinen; Pertti J Pentikäinen
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

5.  SEA0400 fails to alter the magnitude of intracellular Ca2+ transients and contractions in Langendorff-perfused guinea pig heart.

Authors:  Norbert Szentandrássy; Péter Birinyi; Gyula Szigeti; Attila Farkas; János Magyar; András Tóth; László Csernoch; András Varró; Péter P Nánási
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-05-06       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.